neuromuscular blocking agent
Showing 1 - 25 of >10,000
Remimazolam and Remifentanil Without Neuromuscular Blocking
Completed
- Myoma;Uterus
- +2 more
-
Seongnam, Korea, Republic ofSeoul National University Bundang Hospital
Apr 21, 2022
Brain Tumor Trial in Seoul (Arm I (MEP))
Recruiting
- Brain Tumor
- Arm I (MEP)
-
Seoul, Korea, Republic ofGangnamSeverance Hospital
Apr 26, 2021
Obesity, Bariatric Surgery Candidate, Intubation Complication Trial in Toulouse (Remifentanil Injection, Remifentanil Injection
Recruiting
- Obesity
- +2 more
- Remifentanil Injection
- Remifentanil Injection plus 30%
-
Toulouse, FranceHospital University of Toulouse
May 30, 2022
"Effects of Neuromuscular Blocking Agents on End Expiratory Lung
Completed
- ARDS
- Neuromuscular Blockade
-
Monza, Lombardia, ItalyASST Monza
Apr 27, 2022
Respiratory Failure, Respiratory Infection, Aspiration Pneumonia Trial in Boston (Neuromuscular Blocking Agents, Anesthetic
Terminated
- Respiratory Failure
- +5 more
- Neuromuscular Blocking Agents
- Anesthetic Adjuncts
-
Boston, Massachusetts
- +1 more
Jan 31, 2023
Neuromuscular Blockade Reversal Agent, Sugammadex, Neostigmine Trial in Seongnam-si (Sugammadex, Neostigmine)
Completed
- Neuromuscular Blockade Reversal Agent
- +4 more
-
Seongnam-si, Gyeonggi-do, Korea, Republic ofSeoul National University Bundang Hospital
Dec 22, 2020
Neuromuscular Blocking Drugs and Reversal
Completed
- Neuromuscular Blockade
- +2 more
- Neuromuscular blocking agents
-
Boston, Massachusetts
- +1 more
Aug 19, 2021
Neostigmine, Neuromuscular Blocking Agents, Muscle Weakness Trial in Sorocaba (Reversal of moderate neuromuscular blockade,
Completed
- Neostigmine
- +2 more
- Reversal of moderate neuromuscular blockade
- +3 more
-
Sorocaba, SP, BrazilSanta Lucina Hospital
May 12, 2022
Urinary Retention Postoperative, Laparoscopic Cholecystectomy, Neuromuscular Blockade Trial (Neostigmine, Sugammadex)
Not yet recruiting
- Urinary Retention Postoperative
- +6 more
- (no location specified)
Mar 20, 2023
Neuromuscular Blockade, Anesthesia, Surgery Trial in Salt Lake City (BX1000, Rocuronium Bromide)
Recruiting
- Neuromuscular Blockade
- +2 more
- BX1000
- Rocuronium Bromide
-
Salt Lake City, UtahResearch Center
Jan 6, 2023
Thyroid Diseases, Surgical Injury, Nerve Monitoring Trial in Seoul (Neostigmine, Normal saline)
Completed
- Thyroid Diseases
- +2 more
- Neostigmine
- Normal saline
-
Seoul, Korea, Republic ofSeoul Metropolitan Government Seoul National University Boramae
Mar 3, 2022
Allergy Trial in Jacksonville (Skin Testing)
Completed
- Allergy
- Skin Testing
-
Jacksonville, FloridaMayo Clinic
Feb 1, 2022
Shoulder Pain, Anesthesia Trial in Leuven (Deep neuromuscular block, Moderate neuromuscular block, Neuromuscular Blocking Agents
Recruiting
- Shoulder Pain
- Anesthesia
- Deep neuromuscular block
- +2 more
-
Leuven, Vlaams-Brabant, BelgiumUniversity Hospitals Leuven
Aug 9, 2022
Neuromuscular Recovery in Surgical Patients Using Machine
Not yet recruiting
- Residual Paralysis, Post Anesthesia
- +2 more
-
Ulm, Baden-Württemberg, Germany
- +1 more
Jul 20, 2022
Neuromuscular Block, Residual Trial in Seoul (Sugammadex, Neostigmine)
Recruiting
- Neuromuscular Block, Residual
-
Seoul, Jongrogu, Korea, Republic ofSeoul National University Hospital
Feb 9, 2023
Anesthesia, General, Neuromuscular Blockade Trial in Seoul (Sugammadex Injection 2mg/kg, Sugammadex Injection 4mg/kg, Sugammadex
Completed
- Anesthesia, General
- Neuromuscular Blockade
- Sugammadex Injection 2mg/kg
- +3 more
-
Seoul, Jongro Gu, Korea, Republic ofSNUH
Oct 20, 2022
Rocuronium, Muscle Weakness, General Anaesthesia Trial in Zagreb (Rocuronium, General anesthesia for surgery)
Enrolling by invitation
- Rocuronium
- +2 more
- Rocuronium
- General anesthesia for surgery
-
Zagreb, CroatiaUHCZagreb
Mar 6, 2022
Neuromuscular Blockade in Intentive Care Unit,Observational
Completed
- Critical Care
- +2 more
- Neuromuscular Blocking Agents
-
Argenteuil, France
- +10 more
Dec 15, 2021
Metastatic Breast Cancer Trial in United States (Enobosarm & Abemaciclib Combo, non-steroidal AI, or steroidal AI (exemestane
Recruiting
- Metastatic Breast Cancer
- Enobosarm & Abemaciclib Combo
- non-steroidal AI, or steroidal AI (exemestane with or without everolimus) or Fulvestrant
-
Chandler, Arizona
- +29 more
Feb 1, 2023
Sugammadex Trial in Taoyuan (Neostigmine and Sugammadex)
Recruiting
- Sugammadex
- Neostigmine and Sugammadex
-
Taoyuan, TaiwanYu-Hsun-Tsai
Mar 8, 2022
DLBCL Trial in San Juan (PF-07901801, Tafasitamab, Lenalidomide)
Not yet recruiting
- Diffuse Large B-Cell Lymphoma
- PF-07901801
- +2 more
-
San Juan, Puerto RicoAuxilio Mutuo Cancer Center
Jan 19, 2023
Respiratory Distress Syndrome, Adult Trial in United States (Hypothermia, Neuromuscular Blocking Agents, Standard of care)
Recruiting
- Respiratory Distress Syndrome, Adult
- Hypothermia
- +2 more
-
Atlanta, Georgia
- +14 more
Oct 5, 2022
COVID-19 Acute Respiratory Distress Syndrome, Sedation Complication, ICU Acquired Weakness Trial (muscle relaxation)
Not yet recruiting
- COVID-19 Acute Respiratory Distress Syndrome
- +2 more
- muscle relaxation
- (no location specified)
Jun 9, 2021
Anesthesia, General, Neuromuscular Blockade Trial in Seoul (Sugammadex Injection 2mg/kg, Sugammadex Injection 4mg/kg, Sugammadex
Completed
- Anesthesia, General
- Neuromuscular Blockade
- Sugammadex Injection 2mg/kg
- +3 more
-
Seoul, Jongro Gu, Korea, Republic ofSNUH
Feb 8, 2022